⌘K
EN
FR
Novartis Pharma Canada inc. Government Contracts in Canada · CanPursue
Suppliers
Novartis Pharma Canada inc.
Also known as: NOVARTIS PHARMA CANADA INC., Novartis Pharma Canada Inc., Novartis Pharma Canada inc.
Observed
Watch
Observed value
$479.7M
Contracts
72
Awards
45
Buyers
12
Overview
Contracts
Awards
Buyers
Categories
Activity
Acquisition de trousses de préparation NETSPOT
Awarded, Aug 1, 2026
Acquisition de trousses de préparation NETSPOT
Awarded, Aug 1, 2026
MÉDECINE NUCLÉAIRE - GÉNÉRATEUR ET AUTRES PRODUITS
Awarded, Nov 30, 2025
MÉDECINE NUCLÉAIRE - GÉNÉRATEUR ET AUTRES PRODUITS
Awarded, Nov 30, 2025
Trousse PSMA
Awarded, Oct 3, 2025
Trousse PSMA
Awarded, Oct 3, 2025
Appel d'offres Partiel Médicaments
Awarded, Jun 5, 2025
Appel d'offres Partiel Médicaments
Awarded, Jun 5, 2025
Solution injectable pour examen diagnostique à la TEP - Cancer de la prostate
Awarded, May 23, 2025
Solution injectable pour examen diagnostique à la TEP - Cancer de la prostate
Awarded, May 23, 2025
TROUSSES NETSPOT POUR PRÉPARATION INJECTION DE GALLIUM 68
Awarded, Apr 29, 2025
TROUSSES NETSPOT POUR PRÉPARATION INJECTION DE GALLIUM 68
Awarded, Apr 29, 2025
TROUSSES NETPOT
Awarded, Apr 28, 2025
TROUSSES NETPOT
Awarded, Apr 28, 2025
Acquisition du traitement CAR-T Kymriah (tisagenlecleucel)
Awarded, Jan 30, 2025
Acquisition du traitement CAR-T Kymriah (tisagenlecleucel)
Awarded, Jan 30, 2025
Trousse PSMA
Awarded, Nov 29, 2024
Trousse PSMA
Awarded, Nov 29, 2024
Trousse NetSpot (Dotatate)
Awarded, Nov 27, 2024
Trousse NetSpot (Dotatate)
Awarded, Nov 27, 2024
ACQUISITION DU KYMRIAH - TISAGENLECLEUCEL (THERAPIE CELLULAIRE)- PHARMACIE
Awarded, Sep 10, 2024
ACQUISITION DU KYMRIAH - TISAGENLECLEUCEL (THERAPIE CELLULAIRE)- PHARMACIE
Awarded, Sep 10, 2024
Médicaments - Partiel
Awarded, Jul 8, 2024
Médicaments - Partiel
Awarded, Jul 8, 2024
Médicaments - Partiel
Awarded, Jul 8, 2024
Acquisition médicament Kymriah
Awarded, Jul 5, 2024
Acquisition médicament Kymriah
Awarded, Jul 5, 2024
Médicaments - Partiel
Awarded, Jun 25, 2024
Médicaments - Partiel
Awarded, May 24, 2024
Médicaments - Partiel
Awarded, May 24, 2024